Cardiology

Top Story

Enrollment begins for feasibility study of heart pump in patients with STEMI needing PCI

May 27, 2017

The first patients have been enrolled in an FDA-approved feasibility study to evaluate a heart pump for reduction of infarct size in patients with STEMI requiring PCI, according to a press release from Abiomed.

The study will assess the safety of the heart pump system (Impella CP, Abiomed) for unloading of the left ventricle prior to PCI in patients with STEMI without cardiogenic shock.

In the Journals

Racial residential segregation associated with systolic BP changes

May 26, 2017
A reduction in exposure to racial residential segregation was linked to lower systolic BP, according to a study in JAMA Internal Medicine. “Our study suggests…
FDA News

Enrollment begun in study of DCB for treatment of arteriovenous fistulas in renal disease

May 26, 2017
Medtronic announced the first patient has been enrolled in a study of a drug-coated balloon to treat failing arteriovenous fistulas in patients with end-stage renal…
Meeting News

COMPASS: Volanesorsen may lower triglyceride levels in patients with hypertriglyceridemia

May 26, 2017
PHILADELPHIA — Confirming results previously announced, patients with hypertriglyceridemia treated with volanesorsen experienced a decrease in their triglyceride…
Meeting News

Few solutions available for type III hyperlipidemia, sitosterolemia, lipoprotein X disorder

May 26, 2017
PHILADELPHIA — Rare lipid disorders can be difficult to diagnose and treat, according to three presentations at the National Lipid Association Scientific Sessions…
More News Headlines »
Advertisement
Advertisement